n-acetylneuraminic acid has been researched along with Neoplasms in 152 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 23 (15.13) | 18.7374 |
1990's | 21 (13.82) | 18.2507 |
2000's | 20 (13.16) | 29.6817 |
2010's | 50 (32.89) | 24.3611 |
2020's | 38 (25.00) | 2.80 |
Authors | Studies |
---|---|
Bhattacherjee, A; Bui, DT; Daskhan, GC; Enterina, JR; Huang, X; Jung, J; Khoo, KH; Klassen, JS; Kuo, CW; Lin, PH; Macauley, MS; Mahal, LK; Mozaneh, F; Raeisimakiani, P; Rodrigues, E; St Laurent, CD; Zandberg, WF | 1 |
Adema, GJ; Büll, C; Cornelissen, LAM; van Houtum, EJH | 1 |
Dong, H; Gao, Y; Huang, X; Wu, X | 1 |
Belmonte, P; Dong, H; Friedman, DJ; Kim Lee, HS; Kizerwetter, M; Rajcula, M; Shapiro, MJ; Shapiro, VS; Theodore, K | 1 |
Cai, Y; Chen, Y; He, P; Hou, X; Li, S; Ma, Y; Wang, Z; Zhang, G; Zhang, X | 1 |
Miyagi, T; Yamamoto, K | 1 |
Cui, M; Liao, Q; Liu, Q; Yang, S | 1 |
Tatsuta, T | 1 |
Chen, M; Deng, Y; Guo, T; Liu, X; Meng, X; Song, Y; Sui, D; Wang, M; Yan, N; Zhang, K | 1 |
Läubli, H; Maslyar, D; Nalle, SC | 1 |
Deng, Y; Du, Z; Gui, Y; Liang, K; Liu, X; Song, Y; Sui, D; Xin, D; Yu, G; Zhai, W | 1 |
Dai, H; Fan, T; Guo, H; He, T; Huang, J; Liao, Q; Qiu, X; Song, S; Wang, Z; Zeng, Z; Zhang, H; Zhao, Y | 1 |
Jain, A; Jiang, N; Lim, J; Wang, JHS | 1 |
Deng, Y; Gao, X; Li, C; Li, J; Li, X; Liu, M; Liu, X; Qiu, Q; Song, Y; Tang, X; Yan, N; Yan, X | 1 |
Chen, X; Kong, H; Li, M; Song, W; Tao, Y; Wang, H; Yi, K; Zheng, C; Zhong, Q | 1 |
Chen, L; Deng, Y; Liu, X; Meng, X; Song, Y; Wang, M; Zhang, H; Zhang, K | 1 |
Bian, J; Lin, J; Liu, F; Liu, X; Luo, Y; Xie, D; Yue, J | 1 |
Adema, GJ; Büll, C; Cornelissen, LAM; Granado, D; Hooijberg, E; Kers-Rebel, ED; Looman, MW; van Houtum, EJH | 1 |
Gu, Z; Guan, P; Liu, Z; Lu, H; Xu, S | 1 |
Chen, Y; Ju, H; Liu, H; Wang, Y; Yang, Y; Zhao, S | 1 |
Abu Izneid, T; Al Saoud, R; Hamrouni, A; Idris, A; Mousa, WK | 1 |
Chen, J; Kejian, S; Ma, L; Wang, M; Ye, L | 1 |
Dong, H; Huang, X; Wu, X | 1 |
Lee, JY; Lee, S; Park, JS; Son, HY; Tangchang, W; Tran, NP; Tran, P; Yoo, SY | 1 |
Deng, Y; Ding, J; Hu, Y; Liao, X; Liu, M; Liu, X; Song, Y; Zhao, B; Zhao, D | 1 |
Chang, X; Cui, H; Geng, Z; Liu, E; Qiu, X; Shao, W; Sun, X; Tang, J; Wang, P; Wang, Z; Xiao, L; Xu, W; Yang, X; Zhang, J; Zhang, L; Zhang, Y | 1 |
Chua, JX; Durrant, LG; Guy, AJ; McIntosh, RS; Ramsland, PA; Soliman, C; Spendlove, I; Vankemmelbeke, M | 1 |
Mao, F; Qu, Z; Skaro, MF; Sun, H; Wu, Y; Xu, Y; Zhao, S; Zhou, Y | 1 |
Deng, Y; Gao, X; Hu, L; Lai, C; Li, C; Liu, M; Liu, X; Luo, X; Qiu, Q; Song, Y; Zhang, H; Zhao, D | 1 |
Cavdarli, S; Delannoy, P; Groux-Degroote, S | 1 |
Bots, STF; Hensen, LCM; Hoeben, RC | 1 |
Deng, Y; Lai, X; Liu, M; Liu, X; Luo, X; Song, Y; Sui, D; Sun, W; Tang, X; Wang, S; Zhang, H; Zhao, D | 1 |
Bartish, M; Del Rincón, SV; Rudd, CE; Saragovi, HU | 1 |
George Vazhappilly, C; Kawanishi, K; Läubli, H; Matar, R; Merheb, M; Sarwar Siddiqui, S | 1 |
Crocker, PR; Murugesan, G; Weigle, B | 1 |
Deng, Y; Li, C; Li, J; Liu, M; Liu, X; Song, Y; Tang, X; Zhang, H; Zhao, D | 1 |
Arena, A; Fierabracci, A; Gianchecchi, E | 1 |
Divsar, F; Fassihi, J; Hasani, Z; Mahani, M; Mahmoudi, F | 1 |
Chen, M; Deng, Y; Hu, M; Lai, X; Li, G; Liu, M; Sun, Y; Wang, S | 1 |
Deng, Y; Di, D; Hu, L; Liu, X; Liu, Y; Luo, X; Peng, B; Song, Y; Zhang, T; Zhou, S | 1 |
Carvalho, LVN; Lima, LRA; Pereira, MC; Pitta, MGR; Rêgo, MJBM; Santos, LGS; Santos, RVC; Sena, WLB; Silva-Filho, AF; Tavares, LB | 1 |
Di, H; Li, J; Li, M; Liu, D; Liu, H | 1 |
Chen, J; Deng, Y; Duan, L; Kang, L; Ling, H; Shi, J; Song, Y; Zhou, S | 1 |
Bhanushali, P; Bovin, N; Chugh, M; Dobrochaeva, K; Galanina, O; Kadam, P; Khasbiullina, N; Kozlov, N; Pazynina, G; Piskarev, V; Shilova, N; Tupitsin, N | 1 |
Anderson, KS; Borges, CR; Castle, EP; Cole, DEC; Cramer, DW; Ferdosi, S; Fu, L; Ho, TH; Le, T; Maranian, P; Pass, HI; Rehder, DS; Wu, X | 1 |
Bellis, SL; Britain, CM; Holdbrooks, AT | 1 |
Asao, T; Kaira, K; Kuwano, H; Yazawa, S; Yokobori, T | 1 |
Adams, OJ; Läubli, H; Stanczak, MA; von Gunten, S | 1 |
Deng, YH; Huang, ZJ; Luo, X; Shi, J; Song, YZ; Wang, MJ; Zheng, JH | 1 |
Kamerling, JP; Schauer, R | 1 |
Chiodelli, P; Monti, E; Paiardi, G; Rusnati, M; Urbinati, C | 1 |
Alaeddine, M; Alric, C; Alric, L; Authier, H; Balard, P; Bernad, J; Coste, A; Couderc, B; Couderc, F; Dardenne, C; Gouazé-Andersson, V; Lefèvre, L; Meunier, E; Pipy, B; Poinsot, V; Prat, M; Segui, B | 1 |
Deng, Y; Hu, L; Li, C; Li, J; Luo, X; Qiu, Q; Song, Y; Wang, M; Zheng, H | 1 |
Chen, G; Deng, Y; Hu, L; Li, C; Liu, M; Liu, X; Luo, X; Qiu, Q; Shi, T; Song, Y; Yan, X; Yang, S; Zhang, H; Zheng, H | 1 |
Cao, F; Cong, L; Liang, C; Liang, L; Sun, D; Xu, S; Xu, W; Yue, J | 1 |
Carlsten, M; Daly, J; O'Dwyer, M | 1 |
Osório, H; Reis, CA | 1 |
Padler-Karavani, V | 1 |
He, X; Liu, JM; Lu, D; Qu, H; Sollogoub, M; Sun, W; Wdzieczak-Bakala, J; Zhang, Y | 1 |
Alsayed, S; Marzouk, S | 1 |
Cui, L; Duan, X; Li, G; Luo, J; Wu, L; Yang, X | 1 |
Hosono, M; Miyagi, T; Shiozaki, K; Takahashi, K; Yamaguchi, K | 1 |
Boligan, KF; Fernandez, LE; Mesa, C; von Gunten, S | 1 |
Gu, J; Lu, J | 1 |
Audfray, A; Beldjoudi, M; Boos, I; Bouras, M; Breiman, A; Busser, B; Coll, JL; Hurbin, A; Imberty, A; Lantuejoul, S; Le Pendu, J; Unverzagt, C; Varrot, A | 1 |
Liu, Y; Sun, XL; Wang, L; Wu, L | 1 |
Ahmed, H; AlSadek, DM; Badr, HA; Djansugurova, LB; Li, CZ; Mathew, MP; Yarema, KJ | 1 |
Begum, R; Patel, KR; Patel, PS; Vajaria, BN | 1 |
Kamada, Y; Miyoshi, E; Moriwaki, K; Sawanobori, A; Takamatsu, S | 1 |
Cai, L; Ji, M; Li, P; Liu, L; Ma, Y; Pan, H; Sheng, N; Wang, C | 1 |
Fernandes, AR; Ferro, T; Gonçalves, M; Lima, FA; Lino, AC; Marques, G; Matos, T; Mohr, E; Monteiro, M; Silva, M; Silva, Z; Tadokoro, CE; van Kooyk, Y; van Vliet, SJ; Videira, PA | 1 |
Hagiwara, A; Kanemitsu, K; Torii, T | 1 |
Bao, JK; Bian, HJ; Chen, F; Chen, J; Ji, N; Li, CY; Liu, B; Zhou, J | 1 |
Mukuria, JC; Okoth, SA; Omwandho, CO; Wasonga, CG | 1 |
Ames, JB; Gervay-Hague, J; Saludes, JP | 1 |
Banerjee, A; Chaudhuri, D; Ghosh, SK; Mittelman, A; Suriano, R; Tiwari, RK | 1 |
Baker, MS; Chick, JM; Clarke, SJ; Haynes, PA; Jankova, L; Kolarich, D; Lee, A; Packer, NH; Robertson, GR; Tsoli, M | 1 |
Fu, Y; He, B; Teng, Y; Wang, C; Xu, L; Zhang, S; Zhang, W; Zhang, X | 1 |
Fujita-Yamaguchi, Y; Koizumi, T; Matsumoto-Takasaki, A; Nakada, H; Nakata, M | 1 |
Cao, H; Chen, X; Chokhawala, HA; Friedmann-Morvinski, D; Ghaderi, D; Huang, S; Hurtado-Ziola, N; Liu, YT; Messer, K; Muthana, S; Padler-Karavani, V; Pu, M; Schwab, R; Secrest, P; Singer, O; Varki, A; Verma, IM; Yu, H | 1 |
Bao, JK; Li, ZY; Liu, B; Ming, M; Wang, SY; Yao, S; Yu, QJ | 1 |
Hassinen, A; Kellokumpu, S; Kihlström, M; Kokkonen, N; Korhonen, K; Pieters, C; Pujol, FM | 1 |
Colomb, F; Delannoy, P; Foulquier, F; Groux-Degroote, S; Harduin-Lepers, A; Krzewinski-Recchi, MA | 1 |
Chandrasekaran, EV; Locke, RD; Matta, KL; Neelamegham, S; Patil, SA; Xia, J; Xue, J | 1 |
Jung, HI; Kim, HO; Kim, JH; Kwak, BS; Lee, S | 1 |
Hata, K; Miyagi, T; Shiozaki, K; Takahashi, K; Yamaguchi, K | 1 |
Bellis, SL; Schultz, MJ; Swindall, AF | 1 |
Furukawa, K; Hamamura, K; Ohkawa, Y; Ohmi, Y | 1 |
Mullen, GE; O'Neill, AS; van den Berg, TK | 1 |
Fujitani, N; Hinou, H; Matsushita, T; Naruchi, K; Nishimura, S; Ohyabu, N; Shimizu, H | 1 |
Catera, M; Chiricolo, M; Dall'Olio, F; Malagolini, N; Osorio, H; Reis, CA | 1 |
Heikinheimo, M; Labdenne, P | 1 |
Hata, K; Miyagi, T; Moriya, S; Wada, T; Yamaguchi, K | 1 |
DAWES, ML; TURUMI, KI | 1 |
KAWASHIMA, Y; KIMURA, A; NAGAI, Y; SATO, H; TURUMI, KI | 1 |
CAMERADA, P; CONGIU, M; LEO, P | 1 |
GASIC, G; GASIC, T | 1 |
EYLAR, EH; WALLACH, DF | 1 |
BABA, T; ISHII, M | 1 |
FORTUNA, A; SANNA, G | 1 |
GUTTMAN, M; KALANT, H; MONS, W | 1 |
Codden, T; Colicis, J; Henry, JP; Legros, FJ; Lenaerts, A; Nuyens, V; Perpete, G; Ramdani, B | 1 |
Abdallah, Z; Beau, JM; Doisneau, G | 1 |
Wu, AM | 1 |
Hata, K; Miyagi, T; Wada, T; Yamaguchi, K | 1 |
Colell, A; Fernandez-Checa, JC; Garcia-Ruiz, C; Mari, M; Morales, A | 1 |
Amsili, S; Argov, Z; Hinderlich, S; Horstkorte, R; Krause, S; Lochmüller, H; Mitrani-Rosenbaum, S; Wiendl, H | 1 |
Chrostek, L; Cylwik, B; Szmitkowski, M | 1 |
Ishizuka, A; Kakehi, K; Kamoda, S; Kinoshita, M; Naka, R | 1 |
Inoue, O; Kaneko, MK; Kato, Y; Mishima, K; Narimatsu, H; Ozaki, Y; Suzuki-Inoue, K; Yamazaki, Y; Yatomi, Y | 1 |
Miyagi, T | 1 |
Feingold, C; Lotan, D; Lotan, R; Mirelman, D | 1 |
Shamberger, RJ | 1 |
Christozova, I; Maneva, A; Michailova, D; Sarbenova, M; Taleva, B | 1 |
Berenson, CS; Lance, P; Miqdadi, JA; Patterson, MA | 1 |
Jensen, AL; Thougaard, AV; Wenck, A | 1 |
Kawakubo, T; Kobayashi, T | 1 |
Roth, J | 1 |
Den Otter, W; Dullens, HF; Vliegenthart, JF; Voshol, H | 1 |
Berkarda, B; Emekli, N; Koç, L; Serdengeçti, S; Yarat, A | 1 |
Berbeć, H; Cybulski, M; Paszkowska, A | 1 |
Veggeberg, S | 1 |
Hellmén, E; Jensen, AL; Thougaard, AV | 1 |
Heatherington, AC; Mercer, AJ; Schuller, J | 1 |
Arseneau, J; Boccia, R; Colowick, AB; Demetri, G; Glaspy, J; Gordon, D; Harmon, D; Hynes, H; Jadeja, JS; Justice, G; Kessler, J; Kuter, D; O'Byrne, J; Prow, D; Richards, D; Rigas, J; Saven, A; Schwartzberg, L | 1 |
Brosman, S; Bukowski, R; Chan, D; Colowick, AB; Fleishman, A; Gayko, U; Glaspy, J; Griffith, H; Jaiyesimi, IA; Meza, LA; Murdoch, M; Rarick, M; Saven, A; Smith, RE; Tchekmedyian, NS | 1 |
Dong, X; Han, F; Lin, B; Ping, X; Xu, X; Yuang, X | 1 |
Polívková, J; Pospísil, J; Poucková, P; Vosmiková, K | 1 |
Horák, L; Polívková, J; Vosmiková, K | 1 |
Graf, N; Seider, A; Sitzmann, FC | 1 |
Hilgers, J; Kenemans, P; Mensdorff-Pouilly, S; Schutter, EM; van Dijk, W; van Kamp, GJ; Visser, JJ | 1 |
Dehne, A; Frank, KH; Laube, K; Laube, N; Simmich, T | 1 |
Higashi, H; Kato, A; Kato, S; Kawai, T; Naiki, M | 1 |
Confort-Gouny, S; Cozzone, PJ; Fayre, R; Fontanarava, E; Harlé, JR; Kriat, M; Maraninchi, D; Sciaky, M; Vion-Dury, J; Viout, P | 1 |
Berns, G; Butler, M; Carroll, K; Fennelly, J; Moran, E; O'Brien, A; O'Kennedy, R; Smyth, H; Thornes, RD | 1 |
Dixit, M; Dwivedi, C; Hardy, RE | 1 |
Brossmer, R; Kemmner, W | 1 |
Schulze, G | 1 |
Cohn, SL; Lincoln, ST; Rosen, ST | 1 |
Hakomori, S | 1 |
Kobayashi, T | 1 |
Murata, K | 1 |
Chacón, I; Daimiel, E; Feliú, J; García Girón, C; González Barón, M; Martín, G; Vicente, J | 1 |
Baten, A; Nabi, ZF; Zucker-Franklin, D | 1 |
Mathé, G; Musset, M; Reizenstein, P | 1 |
Moule, SK; Peak, M; Thompson, S; Turner, GA | 1 |
Chen, YQ; Fan, ZF; Liu, SZ; Tan, RS; Zhang, YH | 1 |
Alhadeff, JA; Plucinsky, MC; Prorok, JJ; Riley, WM | 1 |
Christ, S; Jung, U; Morack, G; Semmler, K; Sydow, G | 1 |
Bedendo, C; Ceriotti, G; Ferrazzi, E; Fiorentino, MV; Maggi, S; Russo, MP; Salvagno, L; Sileni, VC; Tredese, F | 1 |
Adamo, V; Altavilla, G; Caristi, N; Chillemi, S; Giacobello, T; Palmara, D; Scalisi, R | 1 |
Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
41 review(s) available for n-acetylneuraminic acid and Neoplasms
Article | Year |
---|---|
Siglec Signaling in the Tumor Microenvironment.
Topics: Animals; Gene Expression Regulation, Neoplastic; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Ligands; N-Acetylneuraminic Acid; Neoplasms; Sialic Acid Binding Immunoglobulin-like Lectins; Signal Transduction; Tumor Escape; Tumor Microenvironment | 2021 |
Sialidase NEU3 and its pathological significance.
Topics: Cell Membrane; Gangliosides; Humans; N-Acetylneuraminic Acid; Neoplasms; Neuraminidase | 2022 |
Glycosylation of immunoglobin G in tumors: Function, regulation and clinical implications.
Topics: Acetylglucosamine; Fucose; Galactose; Glycosylation; Humans; Immunoglobulin G; N-Acetylneuraminic Acid; Neoplasms | 2022 |
Targeting the Siglec-Sialic Acid Immune Axis in Cancer: Current and Future Approaches.
Topics: Autoimmunity; Humans; Immunity; N-Acetylneuraminic Acid; Neoplasms; Sialic Acid Binding Immunoglobulin-like Lectins | 2022 |
Development of Effective Siglec-9 Antibodies Against Cancer.
Topics: Antibodies; Humans; N-Acetylneuraminic Acid; Neoplasms; Sialic Acid Binding Immunoglobulin-like Lectins; Signal Transduction | 2023 |
Recent advances in the development of sialyltransferase inhibitors to control cancer metastasis: A comprehensive review.
Topics: Cytidine Monophosphate N-Acetylneuraminic Acid; Humans; N-Acetylneuraminic Acid; Neoplasms; Polysaccharides; Sialyltransferases | 2023 |
Topics: Acetylation; Animals; Gangliosides; Humans; Immunotherapy; Molecular Targeted Therapy; N-Acetylneuraminic Acid; Neoplasms | 2020 |
Adenovirus Receptor Expression in Cancer and Its Multifaceted Role in Oncolytic Adenovirus Therapy.
Topics: Adenoviruses, Human; Animals; Cell Line, Tumor; Combined Modality Therapy; Coxsackie and Adenovirus Receptor-Like Membrane Protein; Desmoglein 2; Humans; Integrins; N-Acetylneuraminic Acid; Neoplasms; Oncolytic Virotherapy; Oncolytic Viruses; Receptors, Virus | 2020 |
Aiming for the Sweet Spot: Glyco-Immune Checkpoints and γδ T Cells in Targeted Immunotherapy.
Topics: Animals; Gangliosides; Glycosylation; Humans; Immune Checkpoint Proteins; Immunotherapy, Adoptive; Major Histocompatibility Complex; N-Acetylneuraminic Acid; Neoplasms; Polysaccharides; Receptors, Antigen, T-Cell, gamma-delta; Receptors, Chimeric Antigen; T-Lymphocytes; Tumor Escape; Tumor Microenvironment | 2020 |
Tools to study and target the Siglec-sialic acid axis in cancer.
Topics: Humans; N-Acetylneuraminic Acid; Neoplasms; Neuraminidase; Sialic Acid Binding Immunoglobulin-like Lectins | 2021 |
Siglec and anti-Siglec therapies.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Biomarkers, Tumor; Glycolipids; Glycoproteins; Humans; Immunotherapy; Inflammation; Molecular Targeted Therapy; N-Acetylneuraminic Acid; Neoplasms; Sialic Acid Binding Immunoglobulin-like Lectins | 2021 |
Sialic Acid-Siglec Axis in Human Immune Regulation, Involvement in Autoimmunity and Cancer and Potential Therapeutic Treatments.
Topics: Animals; Autoimmunity; Disease; Glycoproteins; Humans; Immunity, Innate; Immunologic Factors; N-Acetylneuraminic Acid; Neoplasms; Sialic Acid Binding Immunoglobulin-like Lectins | 2021 |
Glycobiology Modifications in Intratumoral Hypoxia: The Breathless Side of Glycans Interaction.
Topics: Animals; Glucose; Glycosylation; Humans; Hypoxia; N-Acetylneuraminic Acid; Neoplasm Proteins; Neoplasms; Polysaccharides | 2017 |
Targeting sialic acid-Siglec interactions to reverse immune suppression in cancer.
Topics: Humans; Immune Tolerance; Immunity, Innate; Immunotherapy; N-Acetylneuraminic Acid; Neoplasms; Sialic Acid Binding Immunoglobulin-like Lectins | 2018 |
Exploration of the Sialic Acid World.
Topics: Animals; Carbohydrate Conformation; Humans; Lysosomal Storage Diseases; Mucolipidoses; N-Acetylneuraminic Acid; Neoplasms; Sialic Acid Storage Disease | 2018 |
Sialic acid as a target for the development of novel antiangiogenic strategies.
Topics: Angiogenesis Inhibitors; Animals; Drug Discovery; Gangliosides; Glycoproteins; Humans; Inflammation; Models, Molecular; Molecular Targeted Therapy; N-Acetylneuraminic Acid; Neoplasms; Neovascularization, Pathologic | 2018 |
Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer.
Topics: Animals; Antigens, Neoplasm; Cytotoxicity, Immunologic; Humans; Immunomodulation; Immunotherapy; Killer Cells, Natural; Molecular Targeted Therapy; N-Acetylneuraminic Acid; Neoplasms; Sialic Acid Binding Immunoglobulin-like Lectins; Sugars | 2019 |
Aiming at the sweet side of cancer: aberrant glycosylation as possible target for personalized-medicine.
Topics: Glycosylation; Humans; N-Acetylneuraminic Acid; Neoplasms; Polysaccharides; Precision Medicine | 2014 |
Plasma membrane-associated sialidase confers cancer initiation, promotion and progression.
Topics: Animals; Cell Survival; Disease Progression; Gangliosides; Humans; N-Acetylneuraminic Acid; Neoplasms; Neuraminidase; Up-Regulation | 2015 |
Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense.
Topics: Glycosylation; Humans; Lectins, C-Type; Models, Biological; N-Acetylneuraminic Acid; Neoplasms; Polysaccharides; Selectins; Sialic Acid Binding Immunoglobulin-like Lectins | 2015 |
Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers.
Topics: beta-D-Galactoside alpha 2-6-Sialyltransferase; Cell Movement; Cell Survival; Disease Progression; Gene Expression Regulation, Enzymologic; Glycosylation; Humans; N-Acetylneuraminic Acid; Neoplasm Metastasis; Neoplasms; Polysaccharides; Sialyltransferases | 2015 |
Sialyltransferase inhibition and recent advances.
Topics: Biocatalysis; Enzyme Inhibitors; Humans; Models, Biological; Models, Chemical; Molecular Structure; N-Acetylneuraminic Acid; Neoplasms; Sialyltransferases | 2016 |
Sialylation: an Avenue to Target Cancer Cells.
Topics: Animals; Carcinogenesis; Humans; N-Acetylneuraminic Acid; Neoplasm Metastasis; Neoplasms; Neuraminidase; Prognosis; Sialoglycoproteins; Sialyltransferases | 2016 |
A glycoproteomic approach to identify novel glycomarkers for cancer stem cells.
Topics: Animals; Biomarkers, Tumor; Cell Separation; Fucose; Glycoproteins; Humans; N-Acetylneuraminic Acid; Neoplasms; Neoplastic Stem Cells; Polysaccharides; Proteome; Proteomics | 2016 |
Sialyltransferases functions in cancers.
Topics: Carbohydrate Sequence; Gene Expression Regulation, Enzymologic; Humans; Molecular Sequence Data; N-Acetylneuraminic Acid; Neoplasms; Sialyltransferases | 2012 |
Sialidase significance for cancer progression.
Topics: Animals; Gene Expression Regulation, Neoplastic; Glycolipids; Glycoproteins; Humans; N-Acetylneuraminic Acid; Neoplasms; Neuraminidase | 2012 |
Regulation of the metastatic cell phenotype by sialylated glycans.
Topics: Animals; Antigens, Tumor-Associated, Carbohydrate; Cell Movement; Glycosylation; Humans; Integrins; Lewis X Antigen; N-Acetylneuraminic Acid; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Phenotype; Polysaccharides; Sialyl Lewis X Antigen | 2012 |
Disialyl gangliosides enhance tumor phenotypes with differential modalities.
Topics: Animals; Gangliosides; Humans; Membrane Microdomains; N-Acetylneuraminic Acid; Neoplasms; Phenotype | 2012 |
Sialoadhesin - a macrophage-restricted marker of immunoregulation and inflammation.
Topics: Animals; Autoimmune Diseases; Biomarkers; Gene Expression Regulation; Humans; Inflammation; Macrophages; N-Acetylneuraminic Acid; Neoplasms; Sialic Acid Binding Ig-like Lectin 1 | 2013 |
Clinical use of tumor markers in childhood malignancies.
Topics: alpha-Fetoproteins; Biomarkers, Tumor; CA-125 Antigen; CA-19-9 Antigen; Catecholamines; Child; Chorionic Gonadotropin; Chromogranin A; Chromogranins; Humans; Infant, Newborn; N-Acetylneuraminic Acid; Neoplasms; Neuropeptide Y; Peptides; Phosphopyruvate Hydratase; Radioimmunodetection | 2002 |
[Regulation of cellular function by mammalian sialidase].
Topics: Animals; Cell Physiological Phenomena; Cloning, Molecular; Diabetes Mellitus; Humans; Mucolipidoses; N-Acetylneuraminic Acid; Neoplasms; Neuraminidase | 2003 |
Sialidase and malignancy: a minireview.
Topics: Animals; Humans; N-Acetylneuraminic Acid; Neoplasm Metastasis; Neoplasms; Neuraminidase | 2004 |
Glycosphingolipids and mitochondria: role in apoptosis and disease.
Topics: Animals; Apoptosis; Cell Death; Drug Resistance, Multiple; Gangliosides; Glucose; Glycosphingolipids; Golgi Apparatus; Humans; Lipids; Mitochondria; Models, Biological; N-Acetylneuraminic Acid; Neoplasms; NF-kappa B; Oxidative Stress; Signal Transduction | 2004 |
[Diagnostic value of total and lipid-bound sialic acid in malignancies].
Topics: Biomarkers, Tumor; Humans; N-Acetylneuraminic Acid; Neoplasm Staging; Neoplasms; Predictive Value of Tests; Prognosis; Sensitivity and Specificity | 2005 |
[Physiological and pathological roles of mammalian sialidases].
Topics: Animals; Apoptosis; Cell Differentiation; Cell Division; Diabetes Mellitus; Humans; Isoenzymes; Lysosomes; Mammals; Mucolipidoses; N-Acetylneuraminic Acid; Neoplasms; Neuraminidase; Signal Transduction | 2008 |
Cellular sialoglycoconjugates: a histochemical perspective.
Topics: Animals; Carbohydrate Sequence; Cell Differentiation; Glycoconjugates; Humans; Immunohistochemistry; Intestines; Kidney; Microscopy, Electron; Molecular Sequence Data; N-Acetylneuraminic Acid; Neoplasms; Organelles; Sialic Acids | 1993 |
[Level of sialic acid in blood serum as a tumor marker].
Topics: Biomarkers, Tumor; Controlled Clinical Trials as Topic; Female; Humans; Male; N-Acetylneuraminic Acid; Neoplasms; Sensitivity and Specificity | 1997 |
The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature.
Topics: Antigens, Neoplasm; Biomarkers, Tumor; Breast Neoplasms; Colonic Neoplasms; Female; Humans; Lipids; Male; N-Acetylneuraminic Acid; Neoplasms; Reference Values; Sialic Acids | 1992 |
Present status of serum tumor markers in diagnosis, prognosis, and evaluation of therapy.
Topics: Acid Phosphatase; alpha-Fetoproteins; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; beta 2-Microglobulin; Calcitonin; Carcinoembryonic Antigen; Creatine Kinase; Humans; Isoenzymes; L-Lactate Dehydrogenase; Lipids; N-Acetylneuraminic Acid; Neoplasms; Phosphopyruvate Hydratase; Prognosis; Sialic Acids | 1986 |
Tumor-associated glycolipid antigens, their metabolism and organization.
Topics: Animals; Antigens, Neoplasm; Blood Group Antigens; Carbohydrate Conformation; Carbohydrate Sequence; Epitopes; Fucose; Gangliosides; Globosides; Glycolipids; Humans; Lactosylceramides; N-Acetylneuraminic Acid; Neoplasms; Sialic Acids | 1986 |
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
4 trial(s) available for n-acetylneuraminic acid and Neoplasms
Article | Year |
---|---|
Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells.
Topics: Animals; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; Endothelial Cells; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Lectins, C-Type; Membrane Glycoproteins; Mice; Mice, Transgenic; N-Acetylneuraminic Acid; Neoplasm Metastasis; Neoplasms; Phospholipase C gamma; Platelet Aggregation; Polysaccharides; Recombinant Proteins; src-Family Kinases; Viper Venoms | 2007 |
Pharmacokinetics of novel erythropoiesis stimulating protein (NESP) in cancer patients: preliminary report.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Darbepoetin alfa; Drug Administration Schedule; Drug Interactions; Erythropoiesis; Erythropoietin; Female; Half-Life; Hemoglobins; Humans; Injections, Subcutaneous; Male; Middle Aged; N-Acetylneuraminic Acid; Neoplasms; Recombinant Proteins; Safety | 2001 |
A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Cohort Studies; Combined Modality Therapy; Darbepoetin alfa; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythrocyte Transfusion; Erythropoiesis; Erythropoietin; Female; Half-Life; Hemoglobins; Humans; Injections, Subcutaneous; Male; Middle Aged; N-Acetylneuraminic Acid; Neoplasms; Recombinant Proteins; Safety; Treatment Outcome | 2001 |
Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Darbepoetin alfa; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythrocyte Transfusion; Erythropoiesis; Erythropoietin; Fatigue; Female; Half-Life; Hemoglobins; Humans; Injections, Subcutaneous; Life Tables; Male; Middle Aged; N-Acetylneuraminic Acid; Neoplasms; Quality of Life; Recombinant Proteins; Safety; Treatment Outcome | 2001 |
107 other study(ies) available for n-acetylneuraminic acid and Neoplasms
Article | Year |
---|---|
Carbohydrate Sulfation As a Mechanism for Fine-Tuning Siglec Ligands.
Topics: Carbohydrate Metabolism; Cell Line; Down-Regulation; Humans; Ligands; Mass Spectrometry; N-Acetylneuraminic Acid; Neoplasms; Protein Binding; Protein Processing, Post-Translational; Sialic Acid Binding Immunoglobulin-like Lectins; Sulfates; Up-Regulation | 2021 |
Synthesis of sialic acid conjugates of the clinical near-infrared dye as next-generation theranostics for cancer phototherapy.
Topics: Humans; Indocyanine Green; N-Acetylneuraminic Acid; Neoplasms; Photochemotherapy; Phototherapy; Precision Medicine | 2022 |
Cutting Edge: Enhanced Antitumor Immunity in ST8Sia6 Knockout Mice.
Topics: Animals; Mice; Mice, Knockout; MicroRNAs; N-Acetylneuraminic Acid; Neoplasms; Sialic Acid Binding Immunoglobulin-like Lectins; Sialyltransferases | 2022 |
Aggregation-Induced Emission (AIE) Photosensitizer Combined Polydopamine Nanomaterials for Organelle-Targeting Photodynamic and Photothermal Therapy by the Recognition of Sialic Acid.
Topics: Animals; Humans; Indoles; Mice; Mice, Inbred BALB C; Mitochondria; N-Acetylneuraminic Acid; Nanostructures; Neoplasms; Photochemotherapy; Photosensitizing Agents; Photothermal Therapy; Polymers | 2022 |
[Basic Research on Bullfrog Egg-derived Sialic Acid-binding Lectin for Cancer Treatment].
Topics: Aldo-Keto Reductases; Animals; Antineoplastic Agents; Apoptosis; ATP-Binding Cassette Transporters; Cell Line, Tumor; EGF Family of Proteins; Humans; Lectins; Ligands; N-Acetylneuraminic Acid; Neoplasms; Pemetrexed; Rana catesbeiana; Ribonucleases; RNA; Tumor Necrosis Factors | 2022 |
Antitumor Immunotherapy of Sialic Acid and/or GM1 Modified Coenzyme Q10 Submicron Emulsion.
Topics: Animals; Emulsions; G(M1) Ganglioside; Immunotherapy; Mice; N-Acetylneuraminic Acid; Neoplasms; Selectins; Ubiquinone | 2022 |
Optimization design of sialic acid derivatives enhances the performance of liposomes for modulating immunosuppressive tumor microenvironments.
Topics: Amides; Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cholesterol; Liposomes; N-Acetylneuraminic Acid; Neoplasms; Tumor Microenvironment | 2022 |
Sialylated IgG in epithelial cancers inhibits antitumor function of T cells via Siglec-7.
Topics: Humans; Immunoglobulin G; N-Acetylneuraminic Acid; Neoplasms; Polysaccharides; Sialic Acid Binding Immunoglobulin-like Lectins; T-Lymphocytes | 2023 |
Persistent immune response: Twice tumor exfoliation induced by sialic acid-modified vincristine sulfate liposomes.
Topics: Animals; Liposomes; Mice; N-Acetylneuraminic Acid; Neoplasms; Tumor Microenvironment; Vincristine | 2023 |
Membrane-Fusion-Mediated Multiplex Engineering of Tumor Cell Surface Glycans for Enhanced NK Cell Therapy.
Topics: Cell Membrane; Cell- and Tissue-Based Therapy; Humans; N-Acetylneuraminic Acid; Neoplasms; Polysaccharides; Sialyltransferases; Tumor Microenvironment | 2023 |
Liposomal Doxorubicin: the Sphingomyelin/Cholesterol System Significantly Enhances the Antitumor Efficacy of Doxorubicin.
Topics: Cell Line, Tumor; Cholesterol; Doxorubicin; Humans; Liposomes; N-Acetylneuraminic Acid; Neoplasms; Sphingomyelins | 2023 |
Sialic acid-targeting multi-functionalized silicon quantum dots for synergistic photodynamic and photothermal cancer therapy.
Topics: Humans; N-Acetylneuraminic Acid; Neoplasms; Photochemotherapy; Photothermal Therapy; Quantum Dots; Reactive Oxygen Species; Silicon | 2023 |
Tumor cell-intrinsic and tumor microenvironmental conditions co-determine signaling by the glycoimmune checkpoint receptor Siglec-7.
Topics: Humans; Ligands; N-Acetylneuraminic Acid; Neoplasms; Sialic Acid Binding Immunoglobulin-like Lectins; Tumor Microenvironment | 2023 |
Leveraging Macrophage-Mediated Cancer Immunotherapy via a Cascading Effect Induced by a Molecularly Imprinted Nanocoordinator.
Topics: Humans; Immunotherapy; Macrophages; N-Acetylneuraminic Acid; Neoplasms; Phagocytosis; Tumor Microenvironment | 2023 |
Topics: Humans; N-Acetylneuraminic Acid; Neoplasms; Sialic Acids | 2023 |
Transforms of Cell Surface Glycoproteins Charge Influences Tumor Cell Metastasis via Atypically Inhibiting Epithelial-Mesenchymal Transition Including Matrix Metalloproteinases and Cell Junctions.
Topics: Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Glycoproteins; Humans; Intercellular Junctions; Matrix Metalloproteinases; Membrane Glycoproteins; N-Acetylneuraminic Acid; Neoplasm Metastasis; Neoplasms | 2023 |
Development of a novel sialic acid-conjugated camptothecin prodrug for enhanced cancer chemotherapy.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Mice; N-Acetylneuraminic Acid; Nanoparticles; Neoplasms; Prodrugs | 2023 |
Sialic acid-decorated liposomes enhance the anti-cancer efficacy of docetaxel in tumor-associated macrophages.
Topics: Animals; Docetaxel; Liposomes; Mice; N-Acetylneuraminic Acid; Neoplasms; NIH 3T3 Cells; Sialic Acid Binding Ig-like Lectin 1; Tissue Distribution; Tumor Microenvironment; Tumor-Associated Macrophages | 2023 |
Terminating the renewal of tumor-associated macrophages: A sialic acid-based targeted delivery strategy for cancer immunotherapy.
Topics: Amines; Animals; Cell Differentiation; Cell Line, Tumor; Disease Models, Animal; Drug Liberation; Epirubicin; Feasibility Studies; Humans; Immunotherapy; Liposomes; Macrophages; Male; Mice; Monocytes; N-Acetylneuraminic Acid; Nanoconjugates; Neoplasms; Rats; RAW 264.7 Cells; Sialic Acid Binding Immunoglobulin-like Lectins; Tissue Distribution; Tumor Microenvironment | 2019 |
Cancer-derived sialylated IgG promotes tumor immune escape by binding to Siglecs on effector T cells.
Topics: Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Female; Humans; Immunoglobulin Fab Fragments; Immunoglobulin G; Lymphocyte Count; Mice; N-Acetylneuraminic Acid; Neoplasms; Protein Binding; Protein Domains; Sialic Acid Binding Immunoglobulin-like Lectins; T-Lymphocytes; Tissue Donors; Tumor Escape; Tumor Microenvironment | 2020 |
The terminal sialic acid of stage-specific embryonic antigen-4 has a crucial role in binding to a cancer-targeting antibody.
Topics: Antibodies, Neoplasm; Antibody Specificity; Carbohydrate Conformation; Humans; Immunoglobulin Fab Fragments; Ligands; Molecular Dynamics Simulation; N-Acetylneuraminic Acid; Neoplasms; Polysaccharides; Stage-Specific Embryonic Antigens | 2020 |
Metabolic Reprogramming in Cancer Is Induced to Increase Proton Production.
Topics: Cell Proliferation; Cell Survival; Cytosol; Energy Metabolism; Female; Glycolysis; Humans; Male; Metabolic Networks and Pathways; Mitochondria; N-Acetylneuraminic Acid; Neoplasms; Nucleotides; Protons; RNA-Seq | 2020 |
Sialic acid-conjugate modified liposomes targeting neutrophils for improved tumour therapy.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Delivery Systems; Interleukin-6; Liposomes; Male; Mice; N-Acetylneuraminic Acid; Neoplasms; Neutrophils; Polyethylene Glycols; Tumor Necrosis Factor-alpha | 2020 |
Targeted delivery of zoledronic acid through the sialic acid - Siglec axis for killing and reversal of M2 phenotypic tumor-associated macrophages - A promising cancer immunotherapy.
Topics: Animals; Cell Line, Tumor; Humans; Immunotherapy; Macrophages; Mice; N-Acetylneuraminic Acid; Neoplasms; Sialic Acid Binding Immunoglobulin-like Lectins; Tumor Microenvironment; Tumor-Associated Macrophages; Zoledronic Acid | 2020 |
Influence of Dose on Neutrophil-Mediated Delivery of Nanoparticles for Tumor-Targeting Therapy Strategies.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Drug Delivery Systems; L-Selectin; Liposomes; Male; Mice; N-Acetylneuraminic Acid; Nanoparticles; Neoplasms; Neutrophils; Particle Size; Sarcoma 180; Tissue Distribution | 2021 |
Carbon dots-embedded N-acetylneuraminic acid and glucuronic acid-imprinted polymers for targeting and imaging of cancer cells.
Topics: Carbon; Glucuronic Acid; Humans; N-Acetylneuraminic Acid; Neoplasms; Polymers; Quantum Dots | 2021 |
Dual targeting single arrow: Neutrophil-targeted sialic acid-modified nanoplatform for treating comorbid tumors and rheumatoid arthritis.
Topics: Animals; Arthritis, Rheumatoid; Liposomes; Mice; N-Acetylneuraminic Acid; Neoplasms; Neutrophils | 2021 |
Targeted delivery of epirubicin to tumor-associated macrophages by sialic acid-cholesterol conjugate modified liposomes with improved antitumor activity.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Cholesterol; Drug Liberation; Drug Stability; Epirubicin; Liposomes; Macrophages; Male; Mice; Myocardium; N-Acetylneuraminic Acid; Neoplasms; Rats, Wistar; RAW 264.7 Cells; Spleen; Thymus Gland; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2017 |
High-Precision Profiling of Sialic Acid Expression in Cancer Cells and Tissues Using Background-Free Surface-Enhanced Raman Scattering Tags.
Topics: Animals; Gene Expression Profiling; Humans; Molecular Imaging; N-Acetylneuraminic Acid; Neoplasm Metastasis; Neoplasms; Single-Cell Analysis; Spectrum Analysis, Raman | 2017 |
Evaluation of the antitumor effects of vitamin K
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cholesterol; Emulsions; Erythrocytes; Hemolysis; Humans; Mice; N-Acetylneuraminic Acid; Nanoparticles; Neoplasms; Rats, Wistar; Tumor Burden; Vitamin K 2 | 2018 |
Glycoprotein CA19.9-specific monoclonal antibodies recognize sialic acid-independent glycotope.
Topics: Animals; Antibodies, Monoclonal; CA-19-9 Antigen; Epitopes; Glycopeptides; Humans; Mice; N-Acetylneuraminic Acid; Neoplasms; Trisaccharides | 2017 |
Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in Cancer.
Topics: Carbohydrate Sequence; Case-Control Studies; Fucose; Glycomics; Glycosylation; Humans; N-Acetylneuraminic Acid; Neoplasms; Polysaccharides; Prognosis | 2018 |
ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor.
Topics: Antigens, CD; Cell Line, Tumor; Cell Survival; Gene Knockdown Techniques; Humans; N-Acetylneuraminic Acid; Neoplasm Proteins; Neoplasms; Protein Processing, Post-Translational; Receptors, Tumor Necrosis Factor, Type I; Sialyltransferases; Signal Transduction; Tumor Microenvironment; Tumor Necrosis Factor-alpha | 2018 |
A new enzyme immunoassay for the determination of highly sialylated and fucosylated human α
Topics: Biomarkers, Tumor; Carcinogenesis; Case-Control Studies; Disease Progression; Fucose; Glycosylation; Humans; Immunoenzyme Techniques; N-Acetylneuraminic Acid; Neoplasms; Orosomucoid; Prognosis | 2018 |
[Pharmacodynamics of liposomes modified with different chain length of sialic acid derivatives].
Topics: Amines; Animals; Cell Line, Tumor; Drug Compounding; Drug Delivery Systems; Humans; Hydrocarbons; Liposomes; Macrophages; Mice; N-Acetylneuraminic Acid; Neoplasms | 2016 |
IL13-Mediated Dectin-1 and Mannose Receptor Overexpression Promotes Macrophage Antitumor Activities through Recognition of Sialylated Tumor Cells.
Topics: Animals; Arginase; Cell Line, Tumor; Gene Expression; Humans; Interleukin-13; Lectins, C-Type; Macrophages; Mannose Receptor; Mannose-Binding Lectins; Mice; Mice, Knockout; N-Acetylneuraminic Acid; Necrosis; Neoplasms; Prognosis; Reactive Oxygen Species; Receptors, Cell Surface; Signal Transduction; T-Lymphocytes | 2019 |
Exhausting tumor associated macrophages with sialic acid-polyethyleneimine-cholesterol modified liposomal doxorubicin for enhancing sarcoma chemotherapy.
Topics: Animals; Cell Line; Cell Survival; Cholesterol; Doxorubicin; Drug Liberation; Macrophages; Male; Mice; N-Acetylneuraminic Acid; Neoplasms; Polyethylene Glycols; Polyethyleneimine; Rats, Wistar; Sarcoma | 2019 |
Targeted delivery of ibrutinib to tumor-associated macrophages by sialic acid-stearic acid conjugate modified nanocomplexes for cancer immunotherapy.
Topics: Adenine; Animals; Drug Delivery Systems; Immunotherapy; Macrophages; Male; Mice; N-Acetylneuraminic Acid; Nanoparticles; Neoplasms; Phosphatidylglycerols; Piperidines; Proton Magnetic Resonance Spectroscopy; Pyrazoles; Pyrimidines; Rats, Wistar; RAW 264.7 Cells; Stearic Acids | 2019 |
Distinguishing cancer cell lines at a single living cell level via detection of sialic acid by dual-channel plasmonic imaging and by using a SERS-microfluidic droplet platform.
Topics: Animals; Biomarkers, Tumor; Boronic Acids; Cell Line, Tumor; Humans; Lab-On-A-Chip Devices; Metal Nanoparticles; Mice; Microfluidic Analytical Techniques; N-Acetylneuraminic Acid; Neoplasms; Silver; Single-Cell Analysis; Spectrum Analysis, Raman; Sulfhydryl Compounds | 2019 |
Mass spectrometry methods for studying glycosylation in cancer.
Topics: Biomarkers, Tumor; Blood Proteins; Glycopeptides; Glycosylation; Humans; N-Acetylneuraminic Acid; Neoplasms; Oligosaccharides; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2013 |
Synthesis and cytotoxicity assay of four ganglioside GM3 analogues.
Topics: Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cytotoxins; G(M3) Ganglioside; Humans; Keratinocytes; N-Acetylneuraminic Acid; Neoplasms | 2014 |
Sialic acid value in pleural effusion as a diagnostic marker of malignancy.
Topics: Aged; Biomarkers; Female; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Neoplasms; Pleural Effusion; Sensitivity and Specificity; Smoking | 2013 |
Adenovirus carrying gene encoding Haliotis discus discus sialic acid binding lectin induces cancer cell apoptosis.
Topics: Adenoviridae; Apoptosis; Cell Line, Tumor; Genetic Therapy; Humans; N-Acetylneuraminic Acid; Neoplasms; Sialic Acid Binding Immunoglobulin-like Lectins | 2014 |
A recombinant fungal lectin for labeling truncated glycans on human cancer cells.
Topics: Acetylglucosamine; Agaricales; Carbohydrate Sequence; Cell Line, Tumor; Crystallography, X-Ray; Epitopes; Glycoconjugates; Glycosylation; Humans; Lectins; Molecular Sequence Data; N-Acetylneuraminic Acid; Neoplasms; Oligosaccharides; Polysaccharides; Protein Binding; Recombinant Proteins; Spectrometry, Fluorescence; Staining and Labeling; Thermodynamics; Up-Regulation | 2015 |
Nutrient-deprived cancer cells preferentially use sialic acid to maintain cell surface glycosylation.
Topics: Adenosine Triphosphate; Blotting, Western; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Survival; ErbB Receptors; Glycoconjugates; Glycosylation; Humans; Lectins; Monosaccharides; Mucin-1; N-Acetylneuraminic Acid; Neoplasms; Nucleotides; Real-Time Polymerase Chain Reaction; Sialic Acids; Sialyltransferases | 2015 |
Sialic Acid-Targeted Nanovectors with Phenylboronic Acid-Grafted Polyethylenimine Robustly Enhance siRNA-Based Cancer Therapy.
Topics: Animals; Antineoplastic Agents; Boronic Acids; Cell Death; Cell Line, Tumor; Endocytosis; Gene Silencing; Humans; Mice, Nude; N-Acetylneuraminic Acid; Nanoparticles; Neoplasms; Polyethyleneimine; Proton Magnetic Resonance Spectroscopy; RNA, Small Interfering; Tissue Distribution | 2016 |
Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses.
Topics: Animals; Antigen Presentation; Antigens, Neoplasm; Cancer Vaccines; Cells, Cultured; Cross-Priming; Dendritic Cells; Female; Humans; Immunotherapy; MCF-7 Cells; Mice; Mice, Inbred C57BL; Mice, Transgenic; N-Acetylneuraminic Acid; Neoplasms; T-Lymphocytes, Cytotoxic | 2016 |
Sialic acid level is significantly elevated in IgM enriched protein fraction in sera of cancer patients.
Topics: Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Humans; Immunoglobulin M; N-Acetylneuraminic Acid; Neoplasms; Polyethylene Glycols | 2017 |
A novel sialic acid-specific lectin from Phaseolus coccineus seeds with potent antineoplastic and antifungal activities.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase Inhibitors; Cell Line, Tumor; Erythrocytes; Fungi; Hemagglutination; Humans; Lectins; Mass Spectrometry; Molecular Sequence Data; N-Acetylneuraminic Acid; Neoplasms; Phaseolus; Phytotherapy; Plant Extracts; Plant Lectins; Rabbits; Seeds | 2009 |
Mushroom polysaccharide extracts delay progression of carcinogenesis in mice.
Topics: Animals; Anticarcinogenic Agents; Carcinoma, Hepatocellular; Disease Progression; L-Lactate Dehydrogenase; Liver; Mice; Mice, Inbred CBA; N-Acetylneuraminic Acid; Neoplasms; Pleurotus; Polysaccharides | 2008 |
Synthesis and structural characterization of sialic acid-glutamic acid hybrid foldamers as conformational surrogates of alpha-2,8-linked polysialic acid.
Topics: Amino Acid Sequence; Circular Dichroism; Glutamic Acid; Humans; Molecular Conformation; Molecular Mimicry; N-Acetylneuraminic Acid; Neoplasm Metastasis; Neoplasms; Peptides; Protein Structure, Secondary; Sialic Acids | 2009 |
Sialic acid content of tissue-specific gp96 and its potential role in modulating gp96-macrophage interactions.
Topics: Animals; Cell Communication; Cells, Cultured; Cytokines; Glycosylation; Humans; Macrophages; Membrane Glycoproteins; N-Acetylneuraminic Acid; Neoplasms; Polysaccharides; Protein Binding; Protein Processing, Post-Translational; Rats; Structure-Activity Relationship | 2009 |
Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumor.
Topics: Animals; Cell Membrane; Galactosyltransferases; Gene Expression Regulation, Neoplastic; Glycomics; Glycosylation; Inflammation; Lectins; Liver; Male; Mannosidases; Mice; Mice, Transgenic; N-Acetylneuraminic Acid; Neoplasm Transplantation; Neoplasms; Polysaccharides; Proteome; Proteomics; Receptors, Mitogen; Sarcoma, Experimental; Sialyltransferases | 2011 |
Lectin-based biosensor strategy for electrochemical assay of glycan expression on living cancer cells.
Topics: Biosensing Techniques; Cell Line, Tumor; Cell Survival; Concanavalin A; Electrochemistry; Electrodes; Glass; Glycosylation; Gold; Humans; Immobilized Proteins; Mannose; Metal Nanoparticles; Microscopy, Fluorescence; N-Acetylneuraminic Acid; Nanotubes, Carbon; Neoplasms; Phenothiazines; Plant Lectins; Protein Stability; Ribosome Inactivating Proteins | 2010 |
Preparation of asialo-agalacto-glycophorin A for screening of anti-Tn antibodies.
Topics: Antibodies; Antibodies, Monoclonal; Antigens, Tumor-Associated, Carbohydrate; beta-Galactosidase; Enzyme-Linked Immunosorbent Assay; Epitopes; Glycophorins; Humans; N-Acetylneuraminic Acid; Neoplasm Metastasis; Neoplasms; Neuraminidase; Oligosaccharides; Peptide Library; Polysaccharides | 2010 |
Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer.
Topics: Adenocarcinoma; Animals; Autoantibodies; Biomarkers, Tumor; Breast Neoplasms; Colonic Neoplasms; Humans; Immunization, Passive; Immunoglobulin G; Immunoglobulins, Intravenous; Jurkat Cells; Mice; Mice, Inbred C57BL; N-Acetylneuraminic Acid; Neoplasms | 2011 |
In silico analysis of molecular mechanisms of Galanthus nivalis agglutinin-related lectin-induced cancer cell death from carbohydrate-binding motif evolution hypothesis.
Topics: Amino Acid Motifs; Binding Sites; Cell Death; Computer Simulation; Conserved Sequence; Evolution, Molecular; Galanthus; Hexosamines; Hexoses; Humans; Lectins, C-Type; Mannose Receptor; Mannose-Binding Lectins; Models, Molecular; N-Acetylneuraminic Acid; Neoplasm Proteins; Neoplasms; Phylogeny; Plant Lectins; Protein Binding; Protein Structure, Tertiary; Receptors, Cell Surface; Signal Transduction; Tumor Cells, Cultured | 2011 |
Functional organization of Golgi N- and O-glycosylation pathways involves pH-dependent complex formation that is impaired in cancer cells.
Topics: Animals; Catalytic Domain; Cell Line, Tumor; Chlorocebus aethiops; Chromatography; COS Cells; Flow Cytometry; Fluorescence Resonance Energy Transfer; Glycosylation; Golgi Apparatus; HeLa Cells; Humans; Hydrogen-Ion Concentration; N-Acetylneuraminic Acid; Neoplasms | 2011 |
Characterization of cancer associated mucin type O-glycans using the exchange sialylation properties of mammalian sialyltransferase ST3Gal-II.
Topics: beta-Galactoside alpha-2,3-Sialyltransferase; Biomarkers, Tumor; Carbon Isotopes; Cell Line, Tumor; Electrophoresis, Polyacrylamide Gel; Female; Glycopeptides; Humans; Male; Mucins; N-Acetylneuraminic Acid; Neoplasms; Polysaccharides; Sialyltransferases | 2012 |
Quantitative analysis of sialic acid on erythrocyte membranes using a photothermal biosensor.
Topics: Biosensing Techniques; Boronic Acids; Diabetes Mellitus; Erythrocyte Membrane; Gold; Humans; Microscopy, Electron, Scanning; N-Acetylneuraminic Acid; Neoplasms; Surface Properties; Temperature | 2012 |
Site-specific conformational alteration induced by sialylation of MUC1 tandem repeating glycopeptides at an epitope region for the anti-KL-6 monoclonal antibody.
Topics: Amino Acid Sequence; Antibodies, Monoclonal; Antibody Affinity; Epitopes; Glycosylation; Humans; Models, Molecular; Molecular Sequence Data; Mucin-1; N-Acetylneuraminic Acid; Neoplasms; Nuclear Magnetic Resonance, Biomolecular; Peptides; Protein Conformation | 2013 |
Apoptotic cells selectively uptake minor glycoforms of vitronectin from serum.
Topics: Animals; Apoptosis; Biological Transport; Cattle; Cell Line, Tumor; Cell Membrane; HSP70 Heat-Shock Proteins; Humans; N-Acetylneuraminic Acid; Neoplasms; Plant Lectins; Protein Isoforms; Ribosome Inactivating Proteins; Serum; Tubulin; Vitronectin | 2013 |
Serum sialic acid levels in mice with neoplasms.
Topics: Amino Acids; Animals; Lymphatic Diseases; Mice; N-Acetylneuraminic Acid; Neoplasms | 1958 |
Hexosamine and sialic acid contents in cells.
Topics: Amino Sugars; Diploidy; Hexosamines; N-Acetylneuraminic Acid; Neoplasms; Neuraminic Acids; Research Design; Tissue Culture Techniques | 1961 |
[On the behavior of mucoprotein and sialic acid in subjects affected with infectious and neoplastic diseases].
Topics: Hematologic Diseases; Humans; Infections; Lymphatic Diseases; Mucoproteins; N-Acetylneuraminic Acid; Neoplasms | 1959 |
Removal of sialic acid from the cell coat in tumor cells and vascular endothelium, and its effects on metastasis.
Topics: Blood Vessels; Endothelium, Vascular; Glycocalyx; Humans; N-Acetylneuraminic Acid; Neoplasms; Neoplasms, Second Primary; Neuraminic Acids | 1962 |
Sialic acid in the cellular membranes of Ehrlich ascites-carcinoma cells.
Topics: Ascites; Cell Membrane; N-Acetylneuraminic Acid; Neoplasms | 1961 |
[EVALUATION AND MODIFICATION OF SIALIC ACID DETERMINATION METHODS--SIALIC ACID DETERMINATION IN VARIOUS MAMMALIAN TISSUES AS WELL AS IN VARIOUS TUMOR CELLS].
Topics: Animals; Chemistry Techniques, Analytical; Humans; Mammals; N-Acetylneuraminic Acid; Neoplasms; Neuraminic Acids | 1964 |
[VARIATIONS OF SIALIC ACID IN UTERINE NEPLASMS BEFORE AND AFTER RADIUM THERAPY].
Topics: Female; Humans; N-Acetylneuraminic Acid; Neoplasms; Neuraminic Acids; Radium; Uterine Neoplasms | 1964 |
SIALIC ACID CONTENT OF NORMAL RAT LIVER AND OF DAB-INDUCED HEPATOMATA.
Topics: Biochemical Phenomena; Biochemistry; Carcinogens; Carcinoma, Hepatocellular; Chromatography; Liver; Liver Neoplasms; N-Acetylneuraminic Acid; Neoplasms; Neoplasms, Experimental; Neuraminic Acids; Neuraminidase; p-Dimethylaminoazobenzene; Pharmacology; Rats; Research; Toxicology | 1964 |
Analyte comigrating with trisialotransferrin during capillary zone electrophoresis of sera from patients with cancer.
Topics: Alcohol Drinking; Alcoholism; Electrophoresis, Capillary; Female; Glycosylation; Humans; Hydrogen-Ion Concentration; Immune Sera; Male; Middle Aged; N-Acetylneuraminic Acid; Neoplasms; Protein Isoforms; Reference Values; ROC Curve; Transferrin | 2003 |
Synthesis of a carbon-linked mimic of the disaccharide component of the tumor-related SialylTn antigen.
Topics: Antigens, Tumor-Associated, Carbohydrate; Disaccharides; Humans; Molecular Mimicry; Molecular Structure; N-Acetylneuraminic Acid; Neoplasms | 2003 |
Polyvalency of Tn (GalNAcalpha1-->Ser/Thr) glycotope as a critical factor for Vicia villosa B4 and glycoprotein interactions.
Topics: Animals; Antigens, Tumor-Associated, Carbohydrate; Binding Sites; Carbohydrate Sequence; Glycoproteins; Humans; N-Acetylneuraminic Acid; Neoplasms; Oligosaccharides; Plant Lectins; Vicia | 2004 |
Localization of UDP-GlcNAc 2-epimerase/ManAc kinase (GNE) in the Golgi complex and the nucleus of mammalian cells.
Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Brefeldin A; Cell Compartmentation; Cell Nucleus; Cytoplasm; Glycoconjugates; Golgi Apparatus; HeLa Cells; Humans; Jurkat Cells; K562 Cells; Mice; Multienzyme Complexes; Muscle, Skeletal; Myoblasts; Myositis, Inclusion Body; N-Acetylneuraminic Acid; Neoplasms; Nocodazole; Pluripotent Stem Cells; Protein Synthesis Inhibitors; Protein Transport | 2005 |
Analysis of total N-glycans in cell membrane fractions of cancer cells using a combination of serotonin affinity chromatography and normal phase chromatography.
Topics: Cell Membrane; Chromatography, Affinity; Chromatography, High Pressure Liquid; Humans; Molecular Structure; N-Acetylneuraminic Acid; Neoplasms; Oligosaccharides; Polysaccharides; Serotonin; Tumor Cells, Cultured | 2006 |
Enhancement by retinoic acid of the sensitivity of different tumor cell lines to the sialic acid-specific toxin of Entamoeba histolytica.
Topics: Animals; Cell Line; Drug Synergism; Entamoeba histolytica; Glycoproteins; Humans; Lectins; Mice; N-Acetylneuraminic Acid; Neoplasms; Sialic Acids; Sialoglycoproteins; Toxins, Biological; Tretinoin; Wheat Germ Agglutinins | 1984 |
Serum sialic acid in normals and in cancer patients.
Topics: Benzaldehydes; Humans; N-Acetylneuraminic Acid; Neoplasms; Sialic Acids; Spectrophotometry | 1984 |
Superoxide dismutase and lipid-bound sialic acid in sera from children with cancers and juvenile chronic arthritis.
Topics: Adolescent; Arthritis, Juvenile; Autoimmune Diseases; Biomarkers; Biomarkers, Tumor; Cell Transformation, Neoplastic; Child; Child, Preschool; Hodgkin Disease; Humans; Infant; Lymphoma, Non-Hodgkin; N-Acetylneuraminic Acid; Neoplasms; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors; Sensitivity and Specificity; Sialic Acids; Superoxide Dismutase | 1995 |
n-Butyrate mediation of ganglioside expression of human and murine cancer cells demonstrates relative cell specificity.
Topics: Animals; Butyrates; Butyric Acid; Cell Line; Chromatography, Thin Layer; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; Gangliosides; Humans; Laryngeal Neoplasms; Mice; N-Acetylneuraminic Acid; Neoplasms; Neuraminidase; Sialic Acids; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1995 |
Evaluation of an automated spectrophotometric assay for the determination of total sialic acid in canine serum.
Topics: Analysis of Variance; Animals; Dog Diseases; Dogs; Female; Male; N-Acetylneuraminic Acid; Neoplasms; Reproducibility of Results; Sialic Acids; Spectrophotometry | 1994 |
Prospective investigation of tumor markers and risk assessment in early cancer screening.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Carcinoembryonic Antigen; Female; Ferritins; Follow-Up Studies; Humans; Isoenzymes; Japan; Male; Mass Screening; Middle Aged; N-Acetylneuraminic Acid; Neoplasm Proteins; Neoplasm Staging; Neoplasms; Peptides; Precancerous Conditions; Prospective Studies; Ribonucleases; Sialic Acids; Tissue Polypeptide Antigen | 1994 |
Cell surface glycoconjugates as possible target structures for human natural killer cells: evidence against the involvement of glycolipids and N-linked carbohydrate chains.
Topics: 1-Deoxynojirimycin; Carbohydrate Conformation; Carbohydrate Metabolism; Carbohydrates; Cell Membrane; Flow Cytometry; Glycoconjugates; Glycolipids; Glycosylation; Humans; Killer Cells, Natural; Lectins; Leukemia, Erythroblastic, Acute; Membrane Proteins; N-Acetylneuraminic Acid; Neoplasms; Neuraminidase; Sialic Acids; Trypsin; Tumor Cells, Cultured | 1993 |
Salivary sialic acid and cancer.
Topics: Adolescent; Adult; Aged; Aging; Analysis of Variance; Biomarkers, Tumor; Child; Female; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Neoplasms; Random Allocation; Saliva | 1996 |
Molecular handles open the door to novel biomaterials and cancer therapies.
Topics: Biocompatible Materials; Cell Membrane; HeLa Cells; Humans; Hydrazines; Jurkat Cells; Ketones; Mannosides; N-Acetylneuraminic Acid; Neoplasms; Oligosaccharides | 1998 |
Total serum sialic acid is a general disease marker rather than a specific tumour marker in dogs.
Topics: Animals; Biomarkers; Biomarkers, Tumor; Dog Diseases; Dogs; Female; Male; Mammary Neoplasms, Animal; N-Acetylneuraminic Acid; Neoplasm Staging; Neoplasms; Pregnancy; Reference Values; Sensitivity and Specificity | 1998 |
Determination of sialic acids in the serum of cancer patients by capillary electrophoresis.
Topics: Adult; Biomarkers, Tumor; Blood Chemical Analysis; Electrophoresis, Capillary; Female; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Neoplasms; Neuraminic Acids; Reference Values | 2001 |
[Relation between lipid-bound sialic acid in blood serum and plasma andin human tumors].
Topics: Animals; Biomarkers, Tumor; Breast Neoplasms; Colonic Neoplasms; Female; Humans; Lipids; Mice; Mice, Inbred BALB C; Mice, Nude; N-Acetylneuraminic Acid; Neoplasm Transplantation; Neoplasms; Osteosarcoma; Plasma; Rectal Neoplasms; Sialic Acids | 1992 |
Utilization of determining lipid-bound sialic acid for the diagnosis and further prognosis of cancer.
Topics: Carcinoma, Bronchogenic; Female; Humans; Intestinal Neoplasms; Lipids; Lung Neoplasms; Male; N-Acetylneuraminic Acid; Neoplasms; Prognosis; Rectal Neoplasms; Sialic Acids | 1992 |
[Value of serum sialic acid determination in children].
Topics: Adolescent; Biomarkers, Tumor; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Inflammation; Leukemia; Male; N-Acetylneuraminic Acid; Neoplasms; Reference Values; Sialic Acids | 1992 |
[Sialic acid--an acute phase reactant and a concomitant of tumors].
Topics: Biomarkers, Tumor; Humans; N-Acetylneuraminic Acid; Neoplasms; Reference Values; Sialic Acids | 1991 |
Quantitative determination of N-glycolylneuraminic acid expression in human cancerous tissues and avian lymphoma cell lines as a tumor-associated sialic acid by gas chromatography-mass spectrometry.
Topics: Animals; Biomarkers, Tumor; Cell Line; Chickens; Chromatography; Colonic Neoplasms; Humans; In Vitro Techniques; Liver Neoplasms; Lung Neoplasms; Lymphoma; Marek Disease; Mass Spectrometry; N-Acetylneuraminic Acid; Neoplasms; Neuraminic Acids; Sialic Acids; Stomach Neoplasms | 1991 |
Variations of plasma sialic acid and N-acetylglucosamine levels in cancer, inflammatory diseases and bone marrow transplantation: a proton NMR spectroscopy study.
Topics: Acetylglucosamine; Alanine; Bone Marrow Transplantation; Humans; Inflammation; Longitudinal Studies; Magnetic Resonance Spectroscopy; N-Acetylneuraminic Acid; Neoplasms; Sialic Acids; Time Factors | 1991 |
A critical analysis of the use of sialic acid determination in the diagnosis of malignancy.
Topics: Animals; Ascites; Biomarkers, Tumor; Bipolar Disorder; Breast Neoplasms; Brucellosis; Gastrointestinal Neoplasms; Glycopeptides; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Neoplasms; Mice; N-Acetylneuraminic Acid; Neoplasms; Pronase; Sarcoma, Experimental; Sialic Acids; Terpenes; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1991 |
Plasma lipid-bound sialic acid alterations in neoplastic diseases.
Topics: Adult; Biomarkers, Tumor; Female; Humans; Lipids; Male; N-Acetylneuraminic Acid; Neoplasm Metastasis; Neoplasms; Reference Values; Sialic Acids | 1990 |
A new test to measure homotypic aggregation of human tumour cells.
Topics: Animals; Calcium; Carbohydrates; Cell Aggregation; Colonic Neoplasms; Fucose; Humans; Lectins; Leukemia, Promyelocytic, Acute; Lymphoma; Mice; N-Acetylneuraminic Acid; Neoplasms; Neuraminidase; Neuroblastoma; Proteoglycans; Sialic Acids; Tumor Cells, Cultured | 1990 |
[Sialic acid in the serum--an indicator for malignant growth?].
Topics: Biomarkers, Tumor; Clinical Enzyme Tests; Evaluation Studies as Topic; Female; Humans; Male; N-Acetylneuraminic Acid; Neoplasms; Sialic Acids; Time Factors | 1990 |
Correlation between tumor markers and tumor size.
Topics: alpha-Fetoproteins; Carcinoembryonic Antigen; Ferritins; Humans; Iron; N-Acetylneuraminic Acid; Neoplasm Staging; Neoplasms; Sialic Acids; Time Factors | 1987 |
[Significance of N-acetyl neuraminic acid analysis in clinical tests].
Topics: Collagen Diseases; Diabetes Mellitus; Humans; Liver Diseases; N-Acetylneuraminic Acid; Neoplasms; Reference Values; Sialic Acids | 1989 |
[Usefulness of sialic acid as a tumor marker].
Topics: Biomarkers, Tumor; Humans; N-Acetylneuraminic Acid; Neoplasm Staging; Neoplasms; Sialic Acids | 1989 |
Phorbol ester-induced loss of membrane sialic acid: implications for tumor cytolysis by natural killer cells.
Topics: Cell Membrane; Cytotoxicity, Immunologic; Freeze Fracturing; Humans; Killer Cells, Natural; N-Acetylneuraminic Acid; Neoplasms; Neuraminidase; Sialic Acids; Tetradecanoylphorbol Acetate | 1989 |
Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumors.
Topics: Biomarkers, Tumor; Carcinoembryonic Antigen; Female; Humans; Lipids; Male; N-Acetylneuraminic Acid; Neoplasms; Sensitivity and Specificity; Sialic Acids | 1988 |
Studies of the sialylation and microheterogeneity of human serum alpha 1-acid glycoprotein in health and disease.
Topics: Arthritis, Rheumatoid; Chromatography, Thin Layer; Electrophoresis, Polyacrylamide Gel; Humans; Isoelectric Focusing; Myocardial Infarction; N-Acetylneuraminic Acid; Neoplasms; Orosomucoid; Sialic Acids | 1987 |
Biochemical markers of tumor diathesis and early cancer.
Topics: Animals; Clinical Laboratory Techniques; Disease Susceptibility; Esophageal Neoplasms; Humans; Lung Neoplasms; N-Acetylneuraminic Acid; Neoplasms; Orosomucoid; Polyamines; Rats; Reference Values; Sialic Acids | 1986 |
Total and lipid-associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement.
Topics: Adolescent; Adult; Aged; Blood Proteins; Female; Humans; Lipids; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; N-Acetylneuraminic Acid; Neoplasm Metastasis; Neoplasms; Sialic Acids | 1986 |
[Serum sialic acid levels in cancer, pregnancy and upper respiratory infections].
Topics: Abortion, Threatened; Adolescent; Adult; Female; Fetal Blood; Humans; Infant, Newborn; N-Acetylneuraminic Acid; Neoplasms; Pregnancy; Respiratory Tract Infections; Sialic Acids | 1986 |
Lipid bound sialic acid in cancer patients.
Topics: Breast Neoplasms; Carcinoembryonic Antigen; Female; Glycoproteins; Humans; Lipids; Lung Neoplasms; N-Acetylneuraminic Acid; Neoplasms; Ovarian Neoplasms; Sialic Acids | 1985 |
[Behavior of serum sialic acid levels at various stages of neoplastic disease].
Topics: Breast Neoplasms; Carcinoembryonic Antigen; Female; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Male; N-Acetylneuraminic Acid; Neoplasms; Prognosis; Sarcoma; Sialic Acids; Soft Tissue Neoplasms; Urogenital Neoplasms | 1985 |